Strength of Study Evidence Examined by the FDA in Premarket Approval of Cardiovascular Devices
- 23 December 2009
- journal article
- review article
- Published by American Medical Association (AMA) in JAMA
- Vol. 302 (24) , 2679-2685
- https://doi.org/10.1001/jama.2009.1899
Abstract
Review from JAMA — Strength of Study Evidence Examined by the FDA in Premarket Approval of Cardiovascular DevicesKeywords
This publication has 11 references indexed in Scilit:
- Prioritizing Comparative-Effectiveness Research — IOM RecommendationsNew England Journal of Medicine, 2009
- Clinical Effectiveness of Coronary Stents in Elderly Persons: Results From 262,700 Medicare Patients in the American College of Cardiology–National Cardiovascular Data RegistryJournal of the American College of Cardiology, 2009
- The Medical Device Safety Act of 2009New England Journal of Medicine, 2009
- Reporting Bias in Drug Trials Submitted to the Food and Drug Administration: Review of Publication and PresentationPLoS Medicine, 2008
- DTCA for PTCA — Crossing the Line in Consumer Health Education?New England Journal of Medicine, 2008
- Who is Responsible for Evaluating the Safety and Effectiveness of Medical Devices? The Role of Independent Technology AssessmentJournal of General Internal Medicine, 2007
- A novel multi-array immunoassay device for tumor markers based on insert-plug model of piezoelectric immunosensorBiosensors and Bioelectronics, 2007
- Devices, Drugs, and the Food and Drug AdministrationStroke, 2005
- Medical Device Regulation: An Introduction for the Practicing PhysicianAnnals of Internal Medicine, 2004
- Surrogate End Points in Clinical Trials: Are We Being Misled?Annals of Internal Medicine, 1996